Clinical Trials
70 trialsNovel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
National Institutes of Health Clinical Center (CC)
Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies
National Institutes of Health Clinical Center (CC)
Tumor Related Epilepsy
National Institutes of Health Clinical Center (CC)
A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors
Pfizer
Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
St. Jude Children's Research Hospital
CIPHER
Coherence Neuro Australia Pty Limited
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
M.D. Anderson Cancer Center
A Study of DEG6498 in Participants With Solid Tumors
Degron Therapeutics Co.
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Parabilis Medicines, Inc.
Project: Every Child for Younger Patients With Cancer
Children's Oncology Group
A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations
National Institutes of Health Clinical Center (CC)
Indocyanine Green (ICG) Guided Tumor Resection
St. Jude Children's Research Hospital
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Stanford University
BRIDGES
GT Medical Technologies, Inc.
NBM-BMX Administered Orally to Patients With Solid Tumors or Newly Diagnosed Glioblastoma
Novelwise Pharmaceutical Corporation
EMBRAIN
Odense University Hospital
NST-628
Nested Therapeutics, Inc
Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain Metastases
M.D. Anderson Cancer Center
IPAX BrIGHT
Telix Pharmaceuticals (Innovations) Pty Limited
ReRT
The New York Proton Center
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Iambic Therapeutics, Inc
Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblastoma Multiforme (rGBM)
NaviFUS Corporation
A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patients
NaviFUS Corporation
ELECTRA
Stemline Therapeutics, Inc.
TMZ-CHRONO
Ottawa Hospital Research Institute
ASAP
Avera McKennan Hospital & University Health Center
Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies
Rigel Pharmaceuticals
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
RasCal Therapeutics, Inc.
Clinical, patHOlogical and Imaging Project of nEuro-oncology (HOPE)
Beijing Tiantan Hospital
MOMENTUM
UMC Utrecht
SC-Het-GM-CCS
The Children's Hospital of Zhejiang University School of Medicine
ADORATION
Baptist Health South Florida
A Study of Avutometinib for People With Solid Tumor Cancers
Memorial Sloan Kettering Cancer Center
SELECT-CAR-NK
Essen Biotech
EBNK-ST-001
Essen Biotech
Brain Metastases in Greater Size - Hypofractionated Options Trial (BIGSHOT)
Medical University of South Carolina
BiomarkCBT
Uppsala University
Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer
Australian & New Zealand Children's Haematology/Oncology Group
BRICCS
Mayo Clinic
GCCC 19140
University of Maryland, Baltimore
IPAX-2
Telix Pharmaceuticals (Innovations) Pty Limited
CCANED-CIPHER
Dysplasia Diagnostics Limited
VARTUTRACE
Var2 Pharmaceuticals
FREEDOME
Institut du Cancer de Montpellier - Val d'Aurelle
LIBERATE
University Health Network, Toronto
DETERMINE
Cancer Research UK
DETERMINE
Cancer Research UK
DETERMINE
Cancer Research UK
DETERMINE
Cancer Research UK
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Massive Bio, Inc.